Ramacciato Giovanni, Mercantini Paolo, Petrucciani Niccolò, Ravaioli Matteo, Cucchetti Alessandro, Del Gaudio Massimo, Cescon Matteo, Ziparo Vincenzo, Pinna Antonio Daniele
Department of Surgery, University "Sapienza" of Rome, II Faculty of Medicine, Sant'Andrea Hospital, Rome, Italy.
Am Surg. 2010 Nov;76(11):1189-97.
Several effective treatments are available for patients with small solitary hepatocellular carcinomas (HCCs). Conversely, the management of patients with large or multinodular HCCs is controversial, and the role of surgical resection is not well defined. Between 2000 and 2006, 51 patients with large or multinodular HCC underwent liver resection. Clinicopathologic and follow-up data were prospectively collected and retrospectively reviewed. The perioperative and long-term outcomes were analyzed. Univariate and multivariate analysis of prognostic factors were conducted. Although 20 patients had multinodular HCCs, 31 had large solitary tumors. Perioperative mortality occurred in eight patients and complications in 15. In patients with large solitary tumors, 5-year disease-free and overall survival were 41.3 per cent and 56.1 per cent, respectively. Those with multinodular HCCs demonstrated 5-year disease-free and overall survival rates of 0 per cent and 33.6 per cent, respectively. Liver resection can result in long-term survival in select patients with large or multinodular HCCs, even in select patients with impaired liver function. Large solitary HCCs seem to have better prognoses than multinodular tumors, with lower recurrence and higher survival rates after surgery. Randomized controlled trials comparing resection to other treatment modalities are indicated to determine optimal patient management.
对于小的孤立性肝细胞癌(HCC)患者,有几种有效的治疗方法。相反,对于大的或多结节性HCC患者的治疗存在争议,手术切除的作用尚不明确。在2000年至2006年期间,51例大的或多结节性HCC患者接受了肝切除术。前瞻性收集并回顾性分析了临床病理和随访数据。分析了围手术期和长期结果。对预后因素进行了单因素和多因素分析。虽然20例患者有多结节性HCC,但31例有大的孤立性肿瘤。8例患者发生围手术期死亡,15例出现并发症。在大的孤立性肿瘤患者中,5年无病生存率和总生存率分别为41.3%和56.1%。多结节性HCC患者的5年无病生存率和总生存率分别为0%和33.6%。肝切除可使部分大的或多结节性HCC患者获得长期生存,即使是部分肝功能受损的患者。大的孤立性HCC似乎比多结节性肿瘤预后更好,术后复发率更低,生存率更高。需要进行比较手术切除与其他治疗方式的随机对照试验,以确定最佳的患者管理方案。